Have You Lost Money Investing In Athenex, Inc. Securities? – Kehoe Law Firm, P.C. Class Action Investigation On Behalf Of ATNX Investors Who Have Suffered Losses Greater Than $50,000

is investigating potential securities claims on behalf of investors of Athenex, Inc. (Athenex or the Company) ( NASDAQ: ATNX ) to determine whether the Company engaged in securities fraud or other unlawful business practices.

Metadata

Provider:

GlobeNewswire, Inc.

Retrieved on:

Tuesday, March 2, 2021

Information

Tags:

Stock market, Financial markets, Fraud, Lawsuits, Securities Class Action, Securities fraud, Security, Finance, Milberg, Auction rate security

Geotags:

Philadelphia, Pa, Us, NEW YORK

Organisation:

KEHOE LAW FIRM

Summary

Key Points:

is investigating potential securities claims on behalf of investors of Athenex, Inc. (Athenex or the Company) ( NASDAQ: ATNX ) to determine whether the Company engaged in securities fraud or other unlawful business practices.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, ATNX SECURITIES AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRMS SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, BUSINESS DEVELOPMENT, (215) 792-6676, EXT.
802, [email protected] , [email protected] , [email protected] , TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.

PHILADELPHIA, March 01, 2021 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) to determine whether the Company engaged in securities fraud or other unlawful business practices.

Shares of Athenex dropped significantly after the Company reported Q4 results and received a complete response letter from the FDA expressing concerns about the Company’s new drug application for a drug which treats metastatic breast cancer.

INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, ATNX SECURITIES AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, BUSINESS DEVELOPMENT, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.

Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiff–side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.

This press release may constitute attorney advertising.